SCHEMBL90647

SCHEMBL90647

CN(C)CCCN(C1CCC(C(C)(C)C)CC1)S(=O)(=O)c1ccc2c(c1)/C(=N/O)c1cc(S(=O)(=O)NC3CCC(C(C)(C)C)CC3)ccc1/C2=N\O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.40
KDM4E B2RXH2 5/20 0.40
KMT2A Q03164 4/20 0.40
MEN1 O00255 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NPSR1 Q6W5P4 5/20 0.39
LMNA P02545 4/20 0.39
SMN1; SMN2 Q16637 5/20 0.38
MAPT P10636 3/20 0.38
HTT P42858 2/20 0.38
MAPK1 P28482 1/20 0.38
PARG Q86W56 1/20 0.36
PKM P14618 1/20 0.35
USP2 O75604 1/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34
NPC1 O15118 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
XBP1 P17861 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29558779 1.00 ALDH1A1 (0.40) ALDH1A1KDM4EKMT2AMEN1L3MBTL1
SCHEMBL8768025 1.00 ALDH1A1 (0.40) ALDH1A1KDM4EKMT2AMEN1L3MBTL1
SCHEMBL13366897 0.94 ALDH1A1 (0.36) ALDH1A1KDM4EKMT2AMEN1L3MBTL1
SCHEMBL6113938 0.92 KDM4E (0.47) ALDH1A1KDM4EKMT2AMEN1L3MBTL1
SCHEMBL29558657 0.92 KDM4E (0.47) ALDH1A1KDM4EKMT2AMEN1L3MBTL1
SCHEMBL61260 0.89 PARG (0.49) ALDH1A1KDM4EKMT2AMEN1NPSR1
SCHEMBL61324 0.80 SLC6A2 (0.40) SMN1; SMN2HTTPARGTSHRSLC6A2
SCHEMBL29902416 0.71 PARG (0.50) ALDH1A1KDM4EKMT2AL3MBTL1NPSR1
SCHEMBL60256 0.69 PARG (0.72) ALDH1A1KDM4EKMT2AMEN1LMNA
SCHEMBL31385529 0.68 KDM4E (0.58) ALDH1A1KDM4EKMT2AMEN1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9446021-B2 Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof DOGWOOD PHARMACEUTICALS, INC. (US) 2016-09-20 US disclosed
US-20150313873-A1 Derivatives of Fluorene, Anthracene, Xanthene, Dibenzosuberone and Acridine and Uses Thereof DOGWOOD PHARMACEUTICALS, INC. 2015-11-05 US disclosed
US-9120754-B2 Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof DOGWOOD PHARMACEUTICALS, INC. (US) 2015-09-01 US disclosed
US-20120129837-A1 Derivatives of Fluorene, Anthracene, Xanthene, Dibenzosuberone and Acridine and Uses Thereof ALLERGAN SALES, LLC 2012-05-24 US disclosed
US-8129519-B2 Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof ALLERGAN SALES, LLC 2012-03-06 US disclosed
US-20100137354-A1 DERIVATIVES OF FLUORENE, ANTHRACENE, XANTHENE, DIBENZOSUBERONE AND ACRIDINE AND USES THEREOF ALLERGAN SALES, LLC 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120129837-A1 Derivatives of Fluorene, Anthracene, Xanthene, Dibenzosuberone and Acridine and Uses Thereof WNT1, CTNND1, CTNNB1 ALDH1A1 1583/4885KDM4E 3291/4885KMT2A 4484/4885
US-20150313873-A1 Derivatives of Fluorene, Anthracene, Xanthene, Dibenzosuberone and Acridine and Uses Thereof WNT1, CTNND1, CTNNB1 ALDH1A1 1583/4885KDM4E 3291/4885KMT2A 4484/4885
US-20100137354-A1 DERIVATIVES OF FLUORENE, ANTHRACENE, XANTHENE, DIBENZOSUBERONE AND ACRIDINE AND USES THEREOF WNT1, CTNND1, CTNNB1 ALDH1A1 1583/4885KDM4E 3291/4885KMT2A 4484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.